Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors on Lipoprotein(a) Levels: An Umbrella Review of Meta-analyses of Randomized Controlled Trials. - Qiao W; Feng Y; Wen Z; Dou L; Li Y (Drugs, 2026)